Modulation of Synaptic Plasticity Genes Associated to DNA Damage in a Model of Huntington's Disease
- PMID: 36790580
- DOI: 10.1007/s11064-023-03889-w
Modulation of Synaptic Plasticity Genes Associated to DNA Damage in a Model of Huntington's Disease
Abstract
Huntington's disease (HD) is a disease characterized by the progressive degeneration of nerve cells in the brain. DNA damage has been implicated in many neurological disorders; however, the association between this damage and the impaired signaling related to neurodegeneration is still unclear. The transcription factor c-AMP-responsive element binding protein (CREB) has a relevant role in the neuronal plasticity process regulating the expression of several genes, including brain-derived neurotrophic factor (BDNF). Here we analyzed the direct link between DNA damage and the expression of genes involved in neuronal plasticity. The study was performed in model cell lines STHdhQ7 (wild type) and STHdhQ111 (HD model). Treatment with Etoposide (Eto) was used to induce double-strand breaks (DSBs) to evaluate the DNA damage response (DDR) and the expression of synaptic plasticity genes. Eto treatment induced phosphorylation of ATM (p-ATM) and H2AX (γH2AX), markers of DDR, in both cell lines. Interestingly, upon DNA damage, STHdhQ7 cells showed increased expression of activity-regulated cytoskeleton associated protein (Arc) and BDNF when compared to the HD cell line model. Additionally, Eto induced CREB activation with a differential localization of its co-activators in the cell types analyzed. These results suggest that DSBs impact differentially the gene expression patterns of plasticity genes in the normal cell line versus the HD model. This effect is mediated by the impaired localization of CREB-binding protein (CBP) and histone acetylation in the HD model. Our results highlight the role of epigenetics and DNA repair on HD and therefore we suggest that future studies should explore in depth the epigenetic landscape on neuronal pathologies with the goal to further understand molecular mechanisms and pinpoint therapeutic targets.
Keywords: Arc; BDNF; CREB; DNA damage; Huntington.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death.Apoptosis. 2021 Feb;26(1-2):52-70. doi: 10.1007/s10495-020-01645-x. Epub 2020 Nov 23. Apoptosis. 2021. PMID: 33226552
-
Role of Phosphodiesterases in Huntington's Disease.Adv Neurobiol. 2017;17:285-304. doi: 10.1007/978-3-319-58811-7_11. Adv Neurobiol. 2017. PMID: 28956337 Review.
-
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.Hum Mol Genet. 2015 Sep 1;24(17):4958-70. doi: 10.1093/hmg/ddv218. Epub 2015 Jun 10. Hum Mol Genet. 2015. PMID: 26063761
-
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.Hum Mol Genet. 2015 Apr 1;24(7):1929-44. doi: 10.1093/hmg/ddu609. Epub 2014 Dec 8. Hum Mol Genet. 2015. PMID: 25489053 Free PMC article.
-
Shaping synaptic plasticity: the role of activity-mediated epigenetic regulation on gene transcription.Int J Dev Neurosci. 2013 Oct;31(6):359-69. doi: 10.1016/j.ijdevneu.2013.04.003. Epub 2013 May 9. Int J Dev Neurosci. 2013. PMID: 23665156 Review.
Cited by
-
Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington's Disease: Mechanisms and Potential Therapeutics.Biomedicines. 2023 Aug 16;11(8):2275. doi: 10.3390/biomedicines11082275. Biomedicines. 2023. PMID: 37626771 Free PMC article. Review.
-
Long-term environmental enrichment overcomes depression, learning, and memory impairment in elderly CD-1 mice with maternal sleep deprivation exposure.Front Aging Neurosci. 2023 Apr 24;15:1177250. doi: 10.3389/fnagi.2023.1177250. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37168717 Free PMC article.
References
-
- Vonsattel J-P, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577. https://doi.org/10.1097/00005072-198511000-00003 - DOI - PubMed
-
- Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington’s disease. J Psychiatr Neurosci 31(1):21–29
-
- MacDonald ME, Ambrose CM, Duyao MP et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983. https://doi.org/10.1016/0092-8674(93)90585-E - DOI
-
- Browne SE, Beal MF (2004) The energetics of Huntington’s disease. Neurochem Res 29:531–546. https://doi.org/10.1023/B:NERE.0000014824.04728.dd - DOI - PubMed
-
- Browne SE, Beal MF (2006) Oxidative damage in Huntington’s disease pathogenesis. Antioxid Redox Signal 8:2061–2073. https://doi.org/10.1089/ars.2006.8.2061 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous